Overall, these findings suggest that modulating mitochondrial bioenergetics through Nrf2 activation is a promising therapeutic strategy for neurodegenerative diseases, given the significant energy demands of neurons and their dependence on mitochondria [9]. Here, NFE2L2 is linked to neurodegenerative disease.